Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 6166 matches for

Vaccitech, an Oxford University spinout company developing a universal flu vaccine, among other vaccine-related products, has secured £20 million in Series A financing.

Jo Poulton

Jo Poulton

Supervisor

Chris Redman

Chris Redman

Supervisor

Manu Vatish

Manu Vatish

All MRC Supervisors MRC Supervisors - Population Health, Genomics & Genes Supervisor

José Villar

José Villar

Supervisor

Dagan Wells

Dagan Wells

Supervisor

Suzannah Williams

Suzannah Williams

Supervisor

Krina Zondervan

Krina Zondervan

All MRC Supervisors MRC Supervisors - Population Health, Genomics & Genes Supervisor

Georg Holländer

Georg Holländer

All MRC Supervisors MRC Supervisors - Infection & Immunology Supervisor

Profile picture of Georg Hollander, Head of Department of Paediatrics

Dominic Kelly

Dominic Kelly

All MRC Supervisors MRC Supervisors - Infection & Immunology MRC Supervisors - Population Health, Genomics & Genes Supervisor

Irene Roberts

Irene Roberts

All MRC Supervisors MRC Supervisors - Cancer Supervisor

Peter Sullivan

Peter Sullivan

Supervisor

Philip Goulder

Philip Goulder

Supervisor

Jeffrey K Aronson

Jeffrey K Aronson

Supervisor

Paul Aveyard

Paul Aveyard

All MRC Supervisors MRC Supervisors - Population Health, Genomics & Genes Supervisor

Clare Bankhead

Clare Bankhead

All MRC Supervisors MRC Supervisors - Cancer MRC Supervisors - Population Health, Genomics & Genes Supervisor

Andrew Farmer

Andrew Farmer

All MRC Supervisors MRC Supervisors - Infection & Immunology MRC Supervisors - Population Health, Genomics & Genes Supervisor

Anthony Harnden

Anthony Harnden

All MRC Supervisors MRC Supervisors - Infection & Immunology MRC Supervisors - Population Health, Genomics & Genes Supervisor

Carl Heneghan

Carl Heneghan

All MRC Supervisors MRC Supervisors - Population Health, Genomics & Genes Supervisor

Richard Hobbs

Richard Hobbs

All MRC Supervisors MRC Supervisors - Population Health, Genomics & Genes Supervisor

Susan Jebb

Susan Jebb

All MRC Supervisors MRC Supervisors - Population Health, Genomics & Genes Supervisor

Load More

Similar stories

Oxford spinout trials revolutionary bioelectronic implant to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.

Significant scale-up investment for three Oxford spinouts

Three University of Oxford spinouts have raised significant investment to scale their companies in vehicle automation, quantum computing and medical imaging respectively.

Oxford Innovation Society celebrates pioneering biomedical research and innovation

Last month the Oxford Innovation Society (OIS) hosted an event at Pembroke College which celebrated some of the pioneering translational research and innovation coming out of the University’s Medical Sciences Division.

Oxford spinout Optellum secures $14m funding to advance pioneering AI-powered lung cancer diagnosis technology

Optellum, a University of Oxford spinout that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round.

Oxford spinout MiroBio acquired by Gilead Sciences for $405m

The inflammatory diseases company’s rapid ascent and exit underscores the importance of friendships, partnerships and networks in innovation.

Oxford to receive £7 million to turn bright ideas into global opportunities

The University of Oxford has been awarded more than £7 million, the highest amount of funding given to organisations across the UK, in the latest round of UK Research and Innovation’s (UKRI) Impact Acceleration Account (IAA) funding - aimed at fueling the best, brightest and most disruptive ideas from UK research institutions.